Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
10.2164/jandrol.05165 186 ZhangP.ZhengY.LvY.LiF.SuL.QinY.et al (2020)
Efficacy, safety and tolerability of tesaglitazar when added to the therapeutic regimen of poorly controlled insulin-treated patients with type 2 diabetes
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
We understand that individual results may vary, and we are committed to helping you set realistic expectations and achieve lasting success through expert, compassionate care
US$ 27.39
US$ 29.20
US$ 22.78
US$ 28.08
US$ 28.97
US$ 21.72
US$ 20.52
